- Sitemap
Sitemap
Posts
- Newcastle University announces ground-breaking melanoma biomarker
- Melanoma Focus launches Sentinel Node Biopsy Guideline
- NHS confirms revised stopping and retreatment rules for immunotherapy patients
- Flu vaccination: melanoma immunotherapy patients advised they should still receive jab
- Newcastle biomarker study to be published
- Research into birthmarks and melanoma
- Talking About Melanoma Matters – Discussion Guide
- Professor Martin Gore CBE
- First safe and effective adjuvant therapy for melanoma is now available on the NHS
Pages
- #HowMuchIsEnough Awareness Campaign
- Thank You
- Fundraising
- Shop
- Cart
- Checkout
- My account
- Sitemap
- Training plans
- Triathlon Kit
- Cambridge Half Marathon 2020
- Sun Safety & Skin Awareness
- Skin safety when sailing
- Donate
- Home
- Information & Support
- Video: Immunotherapy Treatment for Patients
- What is Melanoma?
- Summaries of Scientific Papers
- Taking Part in Clinical Trials: Video
- Library
- AVAST-M Trial – Final Results Announced
- Melanoma Taskforce Report
- Melanoma Patients Matter – Report by Pharma
- Weblinks
- Other Organisations
- Talking About Melanoma Matters – Discussion Guide
- Clinical Trials
- Patient Decision Aid
- Sentinel Node Biopsy Guideline
- News & Updates
- Support
- Trustees, Management & Advisers
- Activities
- Meetings
- Members’ Area
Events
- ASICS Manchester Marathon 2019
- 100 Miles in May Challenge Event
- London Marathon Walk 2018
- September 2017: Mucosal Melanoma Guidelines consultation begins
- Focus on Melanoma Meeting, RCP, 13 October 2017
- Melanoma 1000 Virtual Challenge
- Woburn Abbey Triathlon
- Virgin Money London Marathon 2020
- Royal Parks Half Marathon 2019
Newcastle University announces ground-breaking melanoma biomarker
Scientists have developed a new prognostic test to improve doctors’ ability to identify which early-stage patients are at a greater risk of their melanoma spreading. The research, part-funded by Melanoma Focus, uses 2 protein biomarkers to help them assess which patients are at high or low risk of disease progression beyond stage 1.
READ MORETalking About Melanoma Matters – Discussion Guide
Published by Bristol-Myers Squibb in conjunction with the UK’s leading melanoma charities, this guide aims to improve the conversations between patients and their healthcare professionals at diagnosis, treatment and living beyond melanoma. It is based on a survey of more than 100 patients.
READ MOREResearch into birthmarks and melanoma
Newcastle University’s Institute of Genetic Medicine is to study the link between rare types of birthmark and a predisposition to melanoma. The project, supported by a grant from Melanoma Focus, aims to discover what is different at the genetic level in such birthmarks.
READ MORE
Virgin Money London Marathon 2020
If you want to join the long list of supporters who have already taken on this famous marathon to support our work, then please let us know.
READ MORE